Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mark A Matza"'
Publikováno v:
RMD Open, Vol 9, Iss 2 (2023)
Objective To assess outcomes in giant cell arteritis (GCA) patients during and after long-term tocilizumab (TCZ) treatment.Methods Retrospective analysis of GCA patients treated with TCZ at a single centre (2010–2022). Time to relapse and annualise
Externí odkaz:
https://doaj.org/article/e3139aa864324cccb16878159e57df77
Autor:
Mark A, Matza, Cory A, Perugino, Liam, Harvey, Ana D, Fernandes, Zachary S, Wallace, Hang, Liu, Hugues, Allard-Chamard, Shiv, Pillai, John H, Stone
Publikováno v:
Lancet Rheumatol
BACKGROUND: There is strong rationale for interference with T cell co-stimulation in IgG4-related disease (IgG4-RD), but the literature to evaluate this is limited to a single case report. METHODS: We conducted a ten-subject proof-of-concept trial of
Autor:
Mark A Matza, Nicholas Dagincourt, Shalini V Mohan, Andrey Pavlov, Jian Han, John H Stone, Sebastian H Unizony
Publikováno v:
RMD Open. 9:e002923
ObjectiveTo assess outcomes in giant cell arteritis (GCA) patients during and after long-term tocilizumab (TCZ) treatment.MethodsRetrospective analysis of GCA patients treated with TCZ at a single centre (2010–2022). Time to relapse and annualised
Autor:
Mark A. Matza, Sandra P. Rincon, Evin Yucel, April M. Jorge, Aneesh B. Singhal, Carrie A. Coleman, Sacha N. Uljon
Publikováno v:
The New England journal of medicine. 386(16)
Autor:
Mark A. Matza, Naina Rastalsky
Publikováno v:
Musculoskeletal Ultrasound in Rheumatology Review ISBN: 9783030735548
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::238c8ebd0968ed7c00660965b94e0467
https://doi.org/10.1007/978-3-030-73555-5_6
https://doi.org/10.1007/978-3-030-73555-5_6
Publikováno v:
Arthritis careresearchReferences. 73(7)